Export

EN
FR
Ondansetron
Essential medicine status
Section:
2. Medicines for pain and palliative care 2.3. Medicines for other common symptoms in palliative care
ATC codes: A04AA01
EMLc
Indication
Palliative care ICD11 code: QC7A
INN
Ondansetron
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (ondansetron base, as hydrochloride)
Oral > Liquid: 4 mg per 5 mL (ondansetron base)
Oral > Solid: 4 mg (ondansetron base) ; 8 mg (ondansetron base)
EML status history
First added in 2011 (TRS 965)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Age restriction
> 1 month
Therapeutic alternatives
dolasetron (ATC codes: A04AA04)
granisetron (ATC codes: A04AA02)
palonosetron (ATC codes: A04AA05)
tropisetron (ATC codes: A04AA03)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Ondansetron
DrugBank
Ondansetron
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that dolasetron, granisetron, palonosetron and tropisetron be specified as therapeutic alternatives under the square box listing for ondansetron on the EML and EMLc.